- News & Events
- Contact Us
|View printer-friendly version|
|Amgen Announces Award for Science Teaching Excellence in Puerto Rico|
|Call for Nominations|
Nomination Deadline: February 29, 2004
Juncos, Puerto Rico (January 5, 2005) – Amgen Inc. (NASDAQ:AMGN), the world's largest biotechnology company, today announced it is launching the Amgen Award for Science Teaching Excellence, a region-wide recognition program for science education. Two K-12 educators who work in either public or private schools in Puerto Rico will each receive an unrestricted $5,000 award from Amgen, and will be honored at an award dinner in May.
Amgen has offered its teaching award in Puerto Rico since 1998. Recently, Amgen changed the award to focus solely on excellence in science teaching. Amgen also conducts similar programs in California; Colorado; Louisville, Kentucky; Boston and Cambridge, Massachusetts; Rhode Island; and Seattle, Washington.
Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level taught by the science teacher; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award. The letter should describe the teacher's attributes in the areas of creativity, teaching effectiveness, best practice development, and instructional and motivational ability.
Letters should be sent to: Amgen Award for Science Teaching Excellence, Attn: Iris Rivera, Amgen Manufacturing Limited, P.O. Box 4060, Road 31, km 24.6, Juncos, Puerto Rico, 00777-4060. Nominations can also be submitted electronically, at www.Amgen.com/ScienceTeacherAward/. Nominations for the award will be accepted immediately, through February 29, 2004.
Amgen Announces Award for Science Teaching Excellence in Puerto Rico
Amgen is a leading global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks